Neostigmine is a treatment option for colonic pseudoobstruction. However, experience in using neostigmine for this indication in pregnant women is limited. We present a case of a woman with an estimated fetal gestational age of 34 weeks presented with what was believed to be a pseudoobstruction and when conservative management failed, neostigmine was administered with no adverse side effects. Ultimately, the patient was found to have a mechanical obstruction and we discuss the challenges in making this diagnosis in pregnancy. Neostigmine may be a viable alternative to colonoscopy in pregnant women for whom mechanical obstruction is properly excluded.
Introduction
Acute pseudoobstruction is characterized by the symptoms, signs, radiologic appearance of large-bowel obstruction in the absence of any mechanical cause. Between 4 and 35% of cases of colonic pseudoobstruction occur during pregnancy or childbirth, and it has been postulated that elevated progesterone, prostaglandin and glucagon levels, as well as a pressure effect of the gravid uterus may contribute to its development in pregnancy. 1 Pseudoobstruction can be managed conservatively and if the patient's condition does not improve, pharmacologic treatment with neostigmine is an option. Neostigmine is used successfully in the nonpregnant population to decompress medically the colon in cases of pseudoobstruction. 2 
Case
A 41-year-old Gravida 6 Para 0232 presented at 34 weeks estimated fetal gestational age with complaints of episodic abdominal pain and distension. She had a history of chronic constipation, self-treated with laxatives, fiber supplements and intermittent saline enemas. In a prior pregnancy she had an admission for constipation, managed conservatively with bowel rest and a nasogastric tube. She had no prior surgeries. In the week before admission, she reported self-administration of three enemas to induce bowel movements, but reported passing only minimal amounts of flatus and stool. Immediately before seeking medical attention, she tried a home remedy of activated charcoal, which precipitated nausea and vomiting. Physical examination demonstrated a diffusely tender abdomen with no rebound or guarding and an empty rectum. There was no evidence of preterm labor.
Abdominal x-ray demonstrated dilated bowel with air throughout the colon. A gastroenterology consultant felt the presentation was consistent with pseudoobstruction and recommended conservative management with colonoscopic tube placement for decompression if there was no improvement. The surgical service recommended a computed tomography (CT) scan, which was refused by the patient because of her fear of radiation injury to the fetus despite reassurances from the obstetrical team. Approximately 36 h after admission, when the patient's pain and distention worsened despite analgesics and a nasogastric tube, 2 mg of neostigmine were given intravenously over 5 min in the operating room. Because cardiac arrhythmias, EKG changes, cardiac arrest, syncope and hypotension have been reported with the use of neostigmine, the patient's vital signs were continuously monitored by the anesthesia staff, whereas the obstetrical team performed continuous electronic fetal monitoring. Both teams were ready to intubate and perform an emergency cesarean section if deemed necessary for maternal or fetal distress. However, maternal vital signs remained stable and the fetal heart rate tracing remained reassuring.
After neostigmine treatment failed, a colonoscope was passed to attempt decompression. The scope reached the splenic flexure where the colonic mucosa appeared to be dusky and necrotic. The colonoscope was withdrawn and the patient was taken to the operating room for exploratory laparotomy. Before surgery began, the patient was noted to have a metabolic acidosis. Upon entering the abdomen, a portion of the bowel at the splenic flexure was found to be necrotic, and a transverse colon volvulus was discovered. Cesarean section was performed because of the severity of the patient's disease. A viable female weighing 2510 g with Apgars of 7 and 8, and arterial cord pH of 7.28 with a base deficit of 3 was delivered. The patient then underwent a subtotal colectomy from the terminal ileum to distal sigmoid colon with ileostomy. She was extubated on postoperative day 1, had an uncomplicated postoperative course and was discharged home 6 days later. Her daughter was discharged home from the nursery with her mother without complications. The patient underwent a successful ileostomy reversal 2 months later.
Comment
In a recent randomized prospective trial of 21 patients with acute colonic pseudo-obstruction who failed at least 24 h of conservative treatment, 91% had prompt colonic decompression when treated with neostigmine. 2 Neostigmine inhibits the action of the enzyme cholinesterase, increasing the effective concentration of acetylcholine. The drug counteracts the inhibition of gastric tone and motility, overcoming atony, increasing propulsive waves and promoting the movement of intestinal contents. Although pregnant women were specifically excluded from this trial, there are retrospective data suggesting that women are more likely to be neostigmine responders. 3 Pharmacologic therapy would be a preferable, noninvasive option for pregnant women if safe and effective. The predominant cardiovascular effect of neostigmine is bradycardia and the patient must be monitored closely for cholinergic reactions. Atropine should be readily available because of hypersensitivity reactions. Further invasive central hemodynamic monitoring should be considered in the event that assessment of cardiac output and central hemodynamic data may be necessary to guide further therapy. We therefore administered neostigmine in the operating room under controlled conditions while monitoring the patient. Neostigmine is a quaternary ammonium compound that would be expected to undergo placental transfer and there are case reports of the slowing of the fetal heart rate when neostigmine was administered to the mother during anesthesia for nonobstetical surgery. 4 The fetus was continuously monitored and the surgical team was prepared to proceed immediately to cesarean section if necessary. There was no evidence of maternal or fetal compromise with neostigmine administration.
Traditionally, if pseudoobstruction is suspected, mechanical causes of bowel obstruction are sought via colonoscopy or barium enema. CT scan is also a useful test, as it may also provide information about the location and etiology of the obstruction. 5 However, there is evidence in the literature that pseudoobstruction can be diagnosed on the basis of abdominal plain films alone with the use of other modalities if the diagnosis remains unclear based on the X-ray. 2 One duty of the obstetrician is to weigh the given risks of diagnostic modalities such as colonoscopy and barium enema against the need to rule-out obstruction in the pregnant population. In the case of a pregnant woman, the estimated fetal exposure of a barium enema is 2 to 4 rads and it must be used cautiously in pregnancy considering with the other types of radiographic studies performed as 5 rads considered a safe limit for fetal exposure. 6 Colonoscopy can provide both diagnosis and treatment, but it is hazardous given the risk of colonic perforation, and there is insufficient data in the literature regarding fetal risks. 7 Despite initial success, colonic distention may return in a large percentage of patients. In this case, based on higher success rates and lower complication rates with neostigmine therapy, neostigmine was presented as a potentially better option than colonoscopy. The patient was counseled about the risks of both approaches including the potential complications to the fetus, and she consented to therapy with neostigmine.
The authors of the aforementioned prospective trial of neostigmine use in acute colonic pseudoobstruction 2 recommended treatment with neostigmine before colonoscopy in patients with acute colonic pseudoobstruction who failed conservative management. In this case of transverse colon volvulus, the plain film and clinical presentation were consistent with pseudoobstruction. In fact, there are other published cases of obstruction mistaken for pseudoobstruction. In one study of 18 patients with presentation and plain films consistent with acute colonic pseudoobstruction, single-contrast water-soluble enemas identified unsuspected mechanical obstruction in two cases. 8 Therefore, one must be cautious when only clinical presentation and plain films are used to rule out obstruction.
In this case, our diagnostic abilities and modalities were limited by a number of factors. The patient and her family attempted nontraditional methods at relieving her discomfort such as activated charcoal and multiple enemas, and it was unclear how much of her symptoms were caused by this self-treatment. Further, she and her family refused further imaging beyond a flat plate of the abdomen for fear of the potential radiation damage to the fetus. Plain films are often diagnostic in sigmoid and cecal volvulus, but are less reliable in the evaluation of transverse colon volvulus. 9 In fact, the majority of the time in nonpregnant patients, diagnosis of transverse colon volvulus is made intraoperatively with delayed surgical intervention. 9 In this unusual case of transverse colon volvulus, the initial presentation was consistent with pseudoobstruction and neostigmine was given. This case highlights the dilemmas in diagnosis of obstruction in pregnancy, and suggests neostigmine as a potentially safe tool for treating pseudoobstruction in pregnancy.
